T2 Biosystems CS (TTOO)
0.1181 +0.0081 (+7.36%) 12:49 ET [OTC US]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select FieldsSymbol | TTOO | NAOV | BJDX | ||
Company | T2 Biosystems CS | Nanovibronix Inc | Bluejay Diagnostics Inc | ||
Price Information | |||||
Exchange | OTC US | NASDAQ | NASDAQ | ||
Open | 0.1199 | 3.71 | 1.8200 | ||
High | 0.1199 | 3.71 | 2.3300 | ||
Low | 0.1160 | 2.80 | 1.7500 | ||
Last | 0.1181 | 2.84 | 1.9400 | ||
Change | +0.0081 | -0.87 | -0.0210 | ||
% Change | +7.36% | -23.45% | -1.08% | ||
Volume | 2,842 | 216,244 | 775,556 | ||
20-Day Average Volume | 105,062 | 4,986,091 | 3,504,755 | ||
Previous Close | 0.1100 | 3.71 | 1.9400 | ||
Industry | Medical Instruments | Medical Instruments | Medical Instruments | ||
Has Options | No | No | No | ||
Technicals | |||||
20-Day Moving Average | 0.1135 | 5.38 | 2.5706 | ||
20-Day Raw Stochastic | 73.05% | 4.25% | 4.82% | ||
20-Day Relative Strength | 46.42% | 39.29% | 42.00% | ||
Weighted Alpha | -95.58 | -83.83 | -94.70 | ||
Today's Opinion | 88% Sell | 72% Sell | 100% Sell | ||
Previous Opinion | 100% Sell | 64% Sell | 100% Sell | ||
Last Month's Opinion | 100% Sell | 96% Sell | 56% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +7.36% since 04/23/25 | -53.22% since 04/23/25 | +11.31% since 04/23/25 | ||
Low | 0.1050 on 04/28/25 | 2.80 on 04/30/25 | 1.4600 on 04/24/25 | ||
High | 0.1340 on 04/28/25 | 6.24 on 04/24/25 | 2.3300 on 04/30/25 | ||
1-Month | |||||
%Chg | +7.17% since 03/28/25 | -24.80% since 03/28/25 | -50.62% since 03/28/25 | ||
Low | 0.0750 on 04/07/25 | 2.24 on 04/07/25 | 1.4600 on 04/24/25 | ||
High | 0.1340 on 04/28/25 | 16.25 on 04/08/25 | 10.2000 on 04/07/25 | ||
3-Month | |||||
%Chg | -43.76% since 01/30/25 | -56.32% since 01/30/25 | -55.42% since 01/30/25 | ||
Low | 0.0560 on 02/14/25 | 1.92 on 03/14/25 | 1.4600 on 04/24/25 | ||
High | 0.2590 on 02/21/25 | 16.25 on 04/08/25 | 10.2000 on 04/07/25 | ||
6-Month | |||||
%Chg | -87.57% since 10/30/24 | -49.51% since 10/30/24 | -59.76% since 10/30/24 | ||
Low | 0.0560 on 02/14/25 | 1.92 on 03/14/25 | 1.4600 on 04/24/25 | ||
High | 0.9535 on 10/31/24 | 16.25 on 04/08/25 | 12.4500 on 11/05/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 2,315 | 2,817 | 1,075 | ||
Shares Outstanding, K | 21,043 | 759 | 554 | ||
Annual Sales | 7,190,000 | 2,560,000 | 0 | ||
Annual Net Income | -50,080,000 | -3,710,000 | -7,720,000 | ||
Last Quarter Sales | 1,990,000 | 440,000 | 0 | ||
Last Quarter Net Income | -10,120,000 | -1,430,000 | -1,430,000 | ||
60-Month Beta | 0.36 | 1.84 | 0.35 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.57 on 11/14/24 | -3.96 on 11/14/24 | -112.37 on 03/31/25 | ||
Latest Earnings Date | 05/05/25 | 05/21/25 | 05/21/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |